COMMON STOCK PURCHASE WARRANT Nemaura Medical Inc.Common Stock Purchase Warrant • July 30th, 2020 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to 5:00 p.m. (New York City time) on [_____][1] (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nemaura Medical Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elect to receive a Warrant in
NEMAURA MEDICAL INC. and NEVADA AGENCY AND TRANSFER COMPANY, as Warrant Agent Warrant Agency Agreement Dated as of July 30, 2020 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • July 30th, 2020 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus • New York
WARRANT AGENCY AGREEMENT, dated as of July 30, 2020 (“Agreement”), between Nemaura Medical Inc., a corporation organized under the laws of the State of Nevada (the “Company”), and Nevada Agency and Transfer Company (the “Warrant Agent”).
Nemaura Medical, Inc. 57 West 57th Street Manhattan, NY New York, NY 10022 Attn: Dewan F. H. ChowdhuryNemaura Medical Inc. • July 30th, 2020 • Surgical & medical instruments & apparatus • New York
This letter (the “Agreement”) constitutes the agreement between Kingswood Capital Markets a division of Benchmark Investments, Inc. (“Kingswood” or the “Placement Agent”) and Nemaura Medical, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), pursuant to which the Placement Agent shall serve as the placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of 1,586,206 shares of common stock (the “Shares”) of the Company, par value $0.0001 per share (“Common Stock”) and warrants (the “Warrants”) to purchase 793,103 shares of Common Stock (the “Warrant Shares” and, collectively with the Shares and the Warrants, the “Securities”) at a combined purchase price of $7.25 per unit. The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that the Plac
